Home Test Search Results Factor V (5) Activity
Factor V (5) Activity

Justification

In its active form, Factor V is a cofactor, which together with activated Factor X, forms a prothrombinase complex that more efficiently converts prothrombin to thrombin than FXa alone. Congenital deficiency of Factor V leads to Owren’s disease (or parahemophilia), a rare inherited disorder that causes mild to severe bleeding. Deficiencies in Factor V activity may also be acquired secondary to other diseases such as liver disease, disseminated intravascular coagulation (DIC), or the development of a specific factor inhibitor.

STAT: < 24 hours (7 days a week)

Clot-based

Draw Tube: Blue Top

Sample Type: Citrated Plasma

Specimen Requirements

Sample Type Volume Required Minimum Volume Stability
PREFERRED Citrated Plasma 1mL 0.5mL Frozen (-20C): 2 weeks
Frozen (-80C): 6 months
ALTERNATIVE - - - -
REJECTION CRITERIA Thawed in transit, refrozen or clotted sample
SPECIAL INSTRUCTIONS -

General Information

METHODOLOGY Clot-based
STAT TAT < 24 hours (7 days a week)
STAT TAT Performance > 90% of results released in 24 hours 7 days a week
ROUTINE TAT < 3 days (M-F)
ALTERNATIVE NAMES Proaccelerin, Labile Factor, F5, FV
DESCRIPTION This is a clot-based assay for the determination of Factor V Activity level in citrated plasma. Patient sample at three different dilutions is mixed with Factor V Deficient plasma containing normal levels of all other factors, such that the resulting Prothrombin Time is dependent only on the level of Factor V present in the patient sample. This value is compared to a reference curve generated from calibrators with known levels of Factor V Activity.
LIMITATIONS -
NORMAL RANGE 66-150%
ASSOCIATED TESTING -
REFERENCES -
SAMPLE REPORT Upon request
NEW YORK STATE APPROVED No

Test Codes

ORDER CODE P3049
CPT CODE 85220
LOINC CODE 3193-0